Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-CoA acyltransferase 2 pseudogene 1 (ACAA2P1) is a genomic DNA sequence similar to the functional mitochondrial enzyme gene ACAA2, but it does not encode a functional protein. Pseudogenes typically arise from gene duplication or retrotransposition events, resulting in sequences unable to produce active enzymes or receptors. Therefore, ACAA2P1 is not considered a therapeutic target, and there is no evidence describing its involvement in human disease, drug interaction, or therapeutic mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-CoA acyltransferase 2 pseudogene 1 (ACAA2P1).